Showing results (1811-1820 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|March 9, 2026
Transforming cisplatin therapy: a localized, injectable poly(anhydride-ester) depot for safer and more effective head and neck cancer treatmentOmiya Ali Hasan, Randa Mohammed Zaki, Obaid Afzal, et al.
Investigational New Drugs|March 10, 2026
Network pharmacology-based therapeutic intervention of Mentha arvensis targeting cancer and doxorubicin-induced cardiotoxicitySatinder Kaur, Umashanker Navik, Gurjit Kaur Bhatti, et al.
Investigational New Drugs|February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profileSanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Investigational New Drugs|March 22, 2024
Association between albumin-bilirubin grade and plasma trough concentrations of regorafenib and its metabolites M-2 and M-5 at steady-state in Japanese patientsKazuma Fujita, Daiki Taguchi, Koji Fukuda, et al.
Investigational New Drugs|February 22, 2024
First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?Yuanyuan Zhao, Ting Mei, Feifei Na, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
Investigational New Drugs|August 2, 2023
Development and characterization of fused human arginase I for cancer therapySnehal Sainath Jawalekar, Priyanka Sugriv Kawathe, Nisha Sharma, et al.
Investigational New Drugs|August 9, 2023
Cytotoxicity of poly-guanidine in medulloblastoma cell linesGabriel Gallo-Oller, Teresita Díaz de Ståhl, Ayodele Alaiya, et al.
Investigational New Drugs|October 28, 2023
Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosisChunjiang Wang, Wei Sun, Zuojun Li, et al.
Investigational New Drugs|October 14, 2023
Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trialYuan Wu, Xuefeng Zhou, Weiqing Zhao, et al.
Pageof 372